跳至主要内容
临床试验/NCT06587386
NCT06587386已完成4 期

The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function After Interscalene Brachial Plexus Block: a Dose-finding Study

Affiliated Hospital of Jiaxing University1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2025年5月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
55
试验地点
1
主要终点
ED90 of motor function was preserved 72 hours after brachial plexus block

研究概览

简要总结

Explore the minimum effective dose of liposomal bupivacaine for preserving motor function

详细描述

Our research group plans to conduct a dose exploration experiment, using a biased coin design sequential method to explore the 90% minimum effective dose of bupivacaine liposomes for preserving motor function after intermuscular groove brachial plexus block surgery in shoulder arthroscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
41 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 41-65 years ASA physical condition 1-3 BMI 18-30 kg/m2 undergoing arthroscopic shoulder surgery

排除标准

  • Inability to consent to the study pregnancy allergy to local anesthetics preexisting neuropathy cervical pathologies (i.e., herniated disc, myelopathy) chronic pain syndromes (defined as reflex sympathetic dystrophy or complex regional pain syndrome) severe respiratory conditions psychiatric or cognitive disorders that prohibit patients from adhering to the study protocol history of drug or alcohol abuse chronic opioid use (longer than 3 months or daily morphine equivalents more than 5mg/day for 1 month) contraindication for general anesthesia and/or interscalene nerve block and planned open shoulder arthrotomies Muscle related diseases

研究组 & 干预措施

First patient's dose of bupivacaine liposome

Experimental

First patient's use of bupivacaine liposome and next patient's use of bupivacaine liposome

干预措施: First patient Bupivacaine liposome and next patient Bupivacaine liposome (Drug)

next patient's dose of bupivacaine liposome

Experimental

First patient's use of bupivacaine liposome and next patient's use of bupivacaine liposome

干预措施: First patient Bupivacaine liposome and next patient Bupivacaine liposome (Drug)

结局指标

主要结局

ED90 of motor function was preserved 72 hours after brachial plexus block

时间窗: 72 hours after brachial plexus block

Evaluate the effective sensory blockade for maintaining motor function at the time point

次要结局

未报告次要终点

研究者

发起方
Affiliated Hospital of Jiaxing University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Qing-he Zhou

Dr.

Affiliated Hospital of Jiaxing University

研究点 (1)

Loading locations...

相似试验

The Minimum Effective Dose (ED90) of Liposomal... | 临床试验